Updated FDA Recognition of CLSI Breakpoints - Editors in Conversation

Описание: Oversight and guidance for performing antibiotic susceptibility testing can be bewildering. There is an alphabet soup of agencies and bodies involved: FDA, CLSI, and USCAST, to name a few here in the US. How does the Food and Drug Administration, which has regulatory authority over AST, work with a nimble group like the Clinical Laboratory Standards Institute?

Guests:
Romney Humphries, Ph.D., D(ABMM), M(ASCP)
Patricia Simner, Ph.D., D(ABMM)

This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. Editors in conversation is supported by the American Society for Microbiology, which publishes JCM. If you are a member of ASM, you can get up to 50% off the publication fees when you publish in JCM or any of the ASM journals.

Visit https://journals.asm.org/journal/jcm to read articles and/or submit a manuscript.

Follow EIC, Alex McAdam on twitter for JCM updates via   / jclinmicro   and co-host, Elli Theel at   / etheelphd  .

Subscribe to the podcast at https://asm.org/eic

Become an ASM member to receive up to 50% off publishing fees: https://asm.org/joinasm

👍 Subscribe https://goo.gl/mOVHlK

✅ Become an ASM member https://asm.org/Membership

🔬 Learn more https://www.asm.org

📱 Join us on social:

Facebook:   / asmfan  

(𝕏) Twitter:   / asmicrobiology  

Bluesky: https://bsky.app/profile/asm.org

Instagram:   / asmicrobiology